Modulation of immune signaling, bacterial clearance, and corneal integrity by toll-like receptors during streptococcus pneumoniae keratitis

Current Eye Research

Volumn 38, Issue 10, 2013, Pages 1036-1048

  Tullos, Nathan A ^a   Thompson, Hilary W ^b,c   Taylor, Sidney D ^a   Sanders, Melissa ^a   Norcross, Erin W ^d   Tolo, Isaiah ^a   Moore, Quincy ^e   Marquart, Mary E ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c LSU EYE CENTER   (United States)

^d MISSISSIPPI COLLEGE   (United States)

^e PRAIRIE VIEW A AND M UNIVERSITY   (United States)

Author keywords

Keratitis; Mouse; Streptococcus pneumoniae; Toll like receptors

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CLEARANCE; BACTERIAL KERATITIS; BACTERIAL SURVIVAL; C57BL 6 MOUSE; CONTROLLED STUDY; IMMUNOGENETICS; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MOUSE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PNEUMOCOCCAL INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; CORNEA; CYTOKINES; DISEASE MODELS, ANIMAL; EYE INFECTIONS, BACTERIAL; KERATITIS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; PNEUMOCOCCAL INFECTIONS; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84883179523     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2013.804094     Document Type: Article

References (59)

1. Holden BA, Sweeney DF, Sankaridurg PR, Carnt N, Edwards K, Stretton S, et al. Microbial keratitis and vision loss with contact lenses. Eye Contact Lens 2003;29: S131-S134.
2. Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Shivkumar C, Palaniappan R. Epidemiology of bacterial keratitis in a referral centre in south India. Indian J Med Microbiol 2003;21:239-245.
3. Ormerod LD. Causation and management of microbial keratitis in subtropical Africa. Ophthalmology 1987;94: 1662-1668.
4. Bharathi MJ, Ramakrishnan R, Shivakumar C, Meenakshi R, Lionalraj D. Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India. Indian J Ophthalmol 2010;58:497-507.
5. Green M, Apel A, Stapleton F. A longitudinal study of trends in keratitis in Australia. Cornea 2008;27:33-39.
6. Cheung J, Slomovic AR. Microbial etiology and predisposing factors among patients hospitalized for corneal ulceration. Can J Ophthalmol 1995;30:251-255.
7. Asbell P, Stenson S. Ulcerative keratitis: survey of 30 years' laboratory experience. Arch Ophthalmol 1982;100: 77-80.
8. Varaprasathan G, Miller K, Lietman T, Whitcher JP, Cevallos V, Okumoto M, et al. Trends in the etiology of infectious corneal ulcers at the F. I. Proctor Foundation. Cornea 2004;23:360-364.
9. Dethorey G, Daruich A, Hay A, Renard G, Bourges JL. Severe bacterial keratitis referred to ophthalmology emergency departments: a retrospective study of 268 cases. J Fr Ophtalmol 2013;36:129-137.
10. Huang X, Barrett RP, McClellan SA, Hazlett LD. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.Invest Ophthalmol Vis Sci 2005;46:4209-4216.
11. Huang X, Du W, McClellan SA, Barrett RP, Hazlett LD. TLR4 is required for host resistance in Pseudomonas aeruginosa keratitis. Invest Ophthalmol Vis Sci 2006;47: 4910-4916.
12. Kumar A, Yu FS. Toll-like receptors and corneal innate immunity. Curr Mol Med 2006;6:327-337.
13. Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, Sher A. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol 2006;177: 3515-3519.
14. Mullaly SC, Kubes P. The role of TLR2 in vivo following challenge with Staphylococcus aureus and prototypic ligands. J Immunol 2006;177:8154-8163.
15. Means TK, Jones BW, Schromm AB, Shurtleff BA, Smith JA, Keane J, et al. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses. J Immunol 2001;166:4074-4082.
16. Frasnelli ME, Tarussio D, Chobaz-Peclat V, Busso N, So A. TLR2 modulates inflammation in zymosan-induced arthritis in mice. Arthritis Res Ther 2005;7:R370-R379.
17. Aravalli RN, Hu S, Rowen TN, Palmquist JM, Lokensgard Jr. Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J Immunol 2005;175: 4189-4193.
18. Wang JP, Kurt-Jones EA, Shin OS, Manchak MD, Levin MJ, Finberg RW. Varicella-zoster virus activates inflammatory cytokines in human monocytes and macrophages via Tolllike receptor 2. J Virol 2005;79:12658-12666.
19. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, et al. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J Virol 2003;77:4588-4596.
20. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, Wilson CB, et al. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc Natl Acad Sci USA 2000;97:13766-13771.
21. Beutler B. Tlr4: central component of the sole mammalian LPS sensor. Curr Opin Immunol 2000;12:20-26.
22. Yang H, Young DW, Gusovsky F, Chow JC. Cellular events mediated by lipopolysaccharide-stimulated Toll-like receptor 4. MD-2 is required for activation of mitogen-activated protein kinases and Elk-1. J Biol Chem 2000;275: 20861-20866.
23. Malley R, Henneke P, Morse SC, Cieslewicz MJ, Lipsitch M, Thompson CM, et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc Natl Acad Sci USA 2003;100:1966-1971.
24. Srivastava A, Henneke P, Visintin A, Morse SC, Martin V, Watkins C, et al. The apoptotic response to pneumolysin is Toll-like receptor 4 dependent and protects against pneumococcal disease. Infect Immun 2005;73:6479-6487.
25. Branger J, Knapp S, Weijer S, Leemans JC, Pater JM, Speelman P, et al. Role of Toll-like receptor 4 in grampositive and gram-negative pneumonia in mice. Infect Immun 2004;72:788-794.
26. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Cutting edge: recognition of gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J Immunol 1999;163: 1-5.
27. Girgis DO, Sloop GD, Reed JM, O'Callaghan RJ. Susceptibility of aged mice to Staphylococcus aureus keratitis. Curr Eye Res 2004;29:269-275.
28. Moore III QC, McCormick CC, Norcross EW, Onwubiko C, Sanders ME, Fratkin J, et al. Development of a Streptococcus pneumoniae keratitis model in mice. Ophthalmic Res 2009; 42:141-146.
29. McCulloch CE, Searle SR, Neuhaus JM. Generalized, linear, and mixed models. 2nd ed. Hoboken (NJ): Wiley; 2008.
30. Swallow WH, Monahan JF. Monte Carlo comparison of ANOVA, MIVQUE, REML, and ML estimators of variance components. Technometrics. 1984;26:47-57.
31. Edwards D, Berry JJ. The efficiency of simulation-based multiple comparisons. Biometrics 1987;43:913-928.
32. Redfern RL, McDermott AM. Toll-like receptors in ocular surface disease. Exp Eye Res 2010;90:679-687.
33. Sarangi PP, Kim B, Kurt-Jones E, Rouse BT. Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol 2007;81: 11128-11138.
34. Sun Y, Chandra J, Mukherjee P, Szczotka-Flynn L, Ghannoum MA, Pearlman E. A murine model of contact lens-associated Fusarium keratitis. Invest Ophthalmol Vis Sci 2010;51:1511-1516.
35. Song PI, Abraham TA, Park Y, Zivony AS, Harten B, Edelhauser HF, et al. The expression of functional LPS receptor proteins CD14 and Toll-like receptor 4 in human corneal cells. Invest Ophthalmol Vis Sci 2001;42:2867-2877.
36. Ueta M, Nochi T, Jang MH, Park EJ, Igarashi O, Hino A, et al. Intracellularly expressed TLR2s and TLR4s contribution to an immunosilent environment at the ocular mucosal epithelium. J Immunol 2004;173:3337-3347.
37. Dessing MC, Florquin S, Paton JC, Van Der Poll T. Toll-like receptor 2 contributes to antibacterial defence against pneumolysin-deficient pneumococci. Cell Microbiol 2008; 10:237-246.
38. Echchannaoui H, Frei K, Schnell C, Leib SL, Zimmerli W, Landmann R. Toll-like receptor 2 deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. J Infect Dis 2002;186:798-806.
39. Han F, Yu H, Tian C, Li S, Jacobs MR, Benedict-Alderfer C, et al. Role for Toll-like receptor 2 in the immune response to Streptococcus pneumoniae infection in mouse otitis media. Infect Immun 2009;77:3100-3108.
40. Klein M, Obermaier B, Angele B, Pfister HW, Wagner H, Koedel U, et al. Innate immunity to pneumococcal infection of the central nervous system depends on Toll-like receptor (TLR) 2 and TLR4. J Infect Dis 2008;198:1028-1036.
41. Jin X, Lin Z, Xie X. The delayed response of Toll-like receptors may relate to Pseudomonas aeruginosa keratitis exacerbating rapidly at the early stages of infection. Eur J Clin Microbiol Infect Dis 2010;29:231-238.
42. Chamaillard M, Hashimoto M, Horie Y, Masumoto J, Qiu S, Saab L, et al. An essential role for Nod1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat Immunol 2003;4:702-707.
43. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem 2003;278:8869-8872.
44. Masumoto J, Yang K, Varambally S, Hasegawa M, Tomlins SA, Qiu S, et al. Nod1 acts as an intracellular receptor to stimulate chemokine production and neutrophil recruitment in vivo. J Exp Med 2006;203:203-213.
45. Franchi L, Amer A, Body-Malapel M, Kanneganti TD, Ozoren N, Jagirdar R, et al. Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1beta in Salmonella-infected macrophages. Nat Immunol 2006;7: 576-582.
46. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, Goodlett DR, et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature 2001;410:1099-1103.
47. Benko S, Tozser J, Miklossy G, Varga A, Kadas J, Csutak A, et al. Constitutive and UV-B modulated transcription of Nod-like receptors and their functional partners in human corneal epithelial cells. Mol Vis 2008;14:1575-1583.
48. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN. Recognition of peptidoglycan from the microbiota by Nod1 enhances systemic innate immunity. Nat Med 2010; 16:228-231.
49. Juarez-Verdayes MA, Rodriguez-Martinez S, Cancino-Diaz ME, Cancino-Diaz JC. Peptidoglycan and muramyl dipeptide from Staphylococcus aureus induce the expression of VEGF-A in human limbal fibroblasts with the participation of TLR2-NFkappaB and NOD2-EGFR. Graefes Arch Clin Exp Ophthalmol 2013;251:53-62.
50. Vogel C, Marcotte EM. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet 2012;13:227-232.
51. Jayapal KP, Philp RJ, Kok YJ, Yap MG, Sherman DH, Griffin TJ, et al. Uncovering genes with divergent mRNAprotein dynamics in Streptomyces coelicolor. PLoS One 2008; 3:e2097.
52. Maier T, Schmidt A, Guell M, Kuhner S, Gavin AC, Aebersold R, et al. Quantification of mRNA and protein and integration with protein turnover in a bacterium. Mol Syst Biol 2011;7:511
53. Kumar A, Zhang J, Yu FS. Innate immune response of corneal epithelial cells to Staphylococcus aureus infection: role of peptidoglycan in stimulating proinflammatory cytokine secretion. Invest Ophthalmol Vis Sci 2004;45: 3513-3522.
54. Chinnery HR, Carlson EC, Sun Y, Lin M, Burnett SH, Perez VL, et al. Bone marrow chimeras and c-fms conditional blation (Mafia) mice reveal an essential role for resident myeloid cells in lipopolysaccharide/TLR4-induced corneal inflammation. J Immunol 2009;182:2738-2744.
55. Karthikeyan RS, Leal Jr SM, Prajna NV, Dharmalingam K, Geiser DM, Pearlman E, et al. Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or Fusarium. J Infect Dis 2011; 204:942-950.
56. Leal Jr SM, Cowden S, Hsia YC, Ghannoum MA, Momany M, Pearlman E. Distinct roles for Dectin-1 and TLR4 in the pathogenesis of Aspergillus fumigatus keratitis. PLoS Pathog 2010;6:e1000976.
57. Harrison JC, Karcioglu ZA, Johnson MK. Response of leukopenic rabbits to pneumococcal toxin. Curr Eye Res 1982;2:705-710.
58. Norcross EW, Sanders ME, Moore III QC, Marquart ME. Pathogenesis of a clinical ocular strain of Streptococcus pneumoniae and the interaction of pneumolysin with corneal cells. J Bacteriol Parasitol 2011;2:108.
59. Norcross EW, Sanders ME, Moore III QC, Taylor SD, Tullos NA, Caston RR, et al. Active immunization with pneumolysin versus 23-valent polysaccharide vaccine for Streptococcus pneumoniae keratitis. Invest Ophthalmol Vis Sci 2011;52:9232-9243.